Stavanger University Hospital Inflammatory Bowel Disease Trial
ConditionIBD
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16-80
SponsorHelse Stavanger HF
About this trial
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined.
Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Eligibility criteria
Qualifiers
newly diagnosed IBD
Disqualifiers
previous IBD with specific treatment within 10 year
inability to consent
inability to adhere to treatment protocol
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov